Potential Mechanisms Driving the Development of Psoriasis after COVID-19 Vaccine

Abstract

This paper conducts a systematic review of the pathogenesis of psoriasis with the COVID-19 vaccine, using skin inflammation as a key point and delayed inflammatory response and cytokines as potential mechanisms driving psoriasis after COVID-19 vaccination. Reports from the global Centers for Disease Control (CDC) Vaccine Adverse Event Reporting System (VAERS) data reveal that psoriasis can be newly developed or exacerbated following vaccination against novel coronavirus pneumonia (COVID-19) despite global vaccination.